Table 4.
Part of the Plant | Origin | Extract | Subspecies/ Variety |
Experimental Model | Effect | References |
---|---|---|---|---|---|---|
Anti-inflammatory and antinociceptive properties | ||||||
In vitro assay | ||||||
Plant parts | Sweden | Aqueous | n.s. | Prostaglandin biosynthesis assay Platelet activating factor-induced exocytosis assay |
↓↓ prostaglandins by 55% at 200 µg/mL ↓↓ platelet activating factor-induced exocytosis by 78% at 250 µg/mL |
[25] |
Woods | Austria | Methylene chloride | n.s. | 12(S)-lipoxygenase assay | ↓↓ 12[S]-hydroxy-5,8,10,14-eicosatetraenoic acid by 54.0% at 100 µg/mL, 66.2 and 76.2%, | [88] |
Berries | Austria | Methylene chloride | n.s. | ↓↓ 12[S]-hydroxy-5,8,10,14-eicosatetraenoic acid by 66.2% at 100 µg/mL | ||
Ethyl acetate | ↓↓ 12[S]-hydroxy-5,8,10,14-eicosatetraenoic acid by 76.2% at 100 µg/mL | |||||
Plant material (twigs, leaves, and fruits) | Spain | Essential oil | n.s. | Inhibition of nitric oxide production in lipopolysaccharide-activated murine macrophage RAW 264.7 cells | IC50 values from 23.98 to 84.80 µg/mL | [75] |
In vivo assays | ||||||
Berries | Italia | Hydroethanolic (80% ethanol, v/v) |
var. communis | Effects on the inhibition of writhing carrageenin foot edema in male Wistar rats after 7 days of treatment at doses of 100 and 200 mg/kg | ↓↓ carrageenin-foot edema by 60% and 79% at 100 and 200 mg/kg, respectively | [113] |
Turkey | Aqueous | 12.8% inhibition (berries) | [114] | |||
Berries, leaves, and stems | Turkey | Methanolic | var. communis | 18.5% inhibition (stems) 3.9% inhibition (berries) 18.5% inhibition (leaves) |
||
Aqueous | var. saxatilis | 9.1% inhibition (berries) 7.8% inhibition (leaves) |
||||
Methanolic | 30.5% inhibition (berries) 35.2% inhibition (leaves) |
|||||
Aqueous | var. communis | Effects on stimulating response latency in male Swiss albino mice using a hot plate after administration of 100 mg/kg of extract | 4.27% inhibition (stems) 5.36% inhibition (berries) 4.29% inhibition (leaves) |
|||
Methanolic | 4.40% inhibition (stems) 4.11% inhibition (berries) 5.16% inhibition (leaves) |
|||||
Aqueous | var. saxatilis | 3.26% inhibition (stems) 4.32% inhibition (berries) 5.13% inhibition (leaves) |
||||
Methanolic | 3.13% inhibition (stems) 4.05% inhibition (berries) 5.31% inhibition (leaves) |
|||||
Aqueous | var. communis | Effects on carrageenin-induced hind-paw edema in male Swiss albino mice after 360 min of 100 mg/kg extract administration | 65.9% inhibition (stems) 65.1% inhibition (berries) 65.4% inhibition (leaves) |
|||
Methanolic | 54.3% inhibition (stems) 65.8% inhibition (berries) 54.8% inhibition (leaves) |
|||||
Aqueous | var. saxatilis | 69.6% inhibition (stems) 51.9% inhibition (berries) 53.6% inhibition (leaves) |
||||
Methanolic | 65.7% inhibition (stems) 43.4% inhibition (berries) 45.3% inhibition (leaves) |
|||||
Methanolic | var. saxatilis | Effects on PGE2-induced hind-paw edema effects in male Swiss albino mice after 360 min of 100 mg/kg extract administration | 17.6% inhibition (stems) 16.5% inhibition (berries) 16.8% inhibition (leaves) |
|||
Leaves | India | Methanolic | n.s. | In vivo study involving different nociceptive assays (acetic acid-induced writhing, formalin and tail-flick tests) in Swiss albino mice at 100 and 200 mg/kg | ↓↓ writhing response and the late phase related with the formalin test Act centrally since the extract and pethidine effects were blocked by naloxone in the tail-flick test |
[29] |
Berries | Romania | Hydroethanolic microemulsions | n.s. | Effects on paw edema in dextran-induced inflammation Wistar rats’ model | ↓↓ paw edema | [40] |
Berries | Romania | Hydroethanolic microemulsions | n.s. | Kaolin-induced inflammation in Wistar rats’ model | ↓↓ interleukins -1β and 6 expression ↓↓ tumor necrosis factor alfa |
|
Antidiabetic, antihypercholesterolemic and antihyperlipidemic effects | ||||||
In vitro assays | ||||||
Fruits | Turkey | Hydroethanolic (80% ethanol, v/v) |
var. saxatilis | Capacity to inhibit α-amylase activity | Inhibitory value of 29.8% at 3 mg/mL | [66] |
Capacity to inhibit α-glucosidase activity | IC50 value of 4.4 µg/mL | |||||
Leaves | Turkey | Hydroethanolic (80% ethanol, v/v) |
var. saxatilis | Capacity to inhibit the α-amylase activity | Inhibitory value of 84.3% at 3/mg/mL | |
Capacity to inhibit the α-glucosidase activity | IC50 value of 53.6 µg/mL | |||||
Plant material | United Kingdom | Aqueous | n.s. | Effects on glucose movement | ↓↓ glucose diffusion by 6% at 50 g/L | [124] |
In vivo assays | ||||||
Berries | United Kingdom | n.s. | Streptozotocin-induced diabetic mice models for 40 days at doses of 1 g/400 mL | ↓↓ polydipsia Prevent weight losses |
[125] | |
Spain | Aqueous | n.s. | Effects on streptozotocin-induced diabetic rat models after 24 days of treatment at doses of 250 and 500 mg/kg | ↓↓ hypoglycemia in normoglycemic rats | [126] | |
Effects on streptozotocin-induced diabetic rat models after 24 days of treatment at 125 mg/kg | ↓↓ blood glucose levels and mortality index Prevent weight losses |
|||||
Turkey | Oil dissolved in 0.5% of sodium carboxymethyl cellulose | n.s. | Effects on albino Wistar rats after 30 days of treatment at doses of 50, 100 and 200 mg/kg | ↓↓ total cholesterol, oxidized low-density lipoprotein, alanine aminotransferase, and aspartate transaminase levels ↑↑ blood urea nitrogen and creatinine levels |
[33] | |
Plant | n.s. | Methanolic extracts | n.s. | Effects on streptozotocin-nicotinamide induced diabetic rats after 21 days of treatment at doses of 100 and 200 mg/kg | ↓↓ blood glucose levels, total cholesterol, triglycerides, low-density lipoprotein, and very-low-density lipoprotein cholesterols ↑↑ high-density lipoprotein cholesterol |
[31] |
Herbal preparation also composed of Juniperus. communis | Croatia | Hydroethanolic (60% ethanol, v/v) |
n.s. | Effects on alloxan-induced nonobese diabetic NOD mice after 7 days of treatment at 20 mg/kg | ↓↓ glucose and fructosamine levels | [127] |
Antiproliferative effects | ||||||
In vitro assays | ||||||
Berries | Nepal | Aqueous | n.s. | Effects on OECM-1 human gingival squamous cancer cells after 24 h of exposure | Induce apoptosis, exhibiting an IC50 value of 46.20 µg/mL | [128] |
Plant material | n.s | Aqueous | n.s | Effects on CE81T/VGH human esophageal squamous cell carcinoma after 24, 48 and 72 h of exposure | Induce cell cycle arrest at the G0/G1 phase by regulating the expression of p53/p21 and CDKs/cyclins, triggering cell apoptosis by activating both the extrinsic (Fas/FasL/Caspase 8) and intrinsic (Bcl-2/Bax/Caspase 9) apoptosis pathways IC50 values of 68.41, 64.33, and 60.07 µg/mL after 24, 48, and 72 h of exposure, respectively |
[39] |
Effects on CE48T/VGH human esophageal epidermoid carcinoma after 24, 48, and 72 h of exposure | Induce cell-cycle arrest at the G0/G1 phase, by regulating the expression of p53/p21 and CDKs/cyclins, triggering cell apoptosis by activating both the extrinsic (Fas/FasL/Caspase 8) and intrinsic (Bcl-2/Bax/Caspase 9) apoptosis pathways IC50 values of 69.38, 56.96, and 36.10 µg/mL after 24, 48, and 72 h of exposure, respectively |
|||||
USA | Distilled extracts | Effects on B16/F10 melanoma cells after 24 and 48 h of exposure | Induced apoptosis, decreased angiogenesis and metastasis, and diminished cancer stem-cell expression IC50 values of 27 and 44 µg/mL, after 24 and 48 h of exposure, respectively |
[73] | ||
Leaves | Turkey | Methanolic | n.s. | Effects on C6 rat brain tumor and HeLa human cervix carcinoma cells after 24 h of exposure | IC50 value of 28.43 µg/mL (C6 rat brain tumor) IC50 value of 32.96 µg/mL (HeLa cancer cells) |
[72] |
Aerial parts | Egypt | Methanolic | n.s. | Effects on PC3 human prostate, HCT 116 human colon, and MCF7 breast cancer cells after 24 h of exposure | IC50 value of 23.8 µg/mL (PC3 cancer cells) IC50 value of 37.6 µg/mL (HCT 116 cancer cells) IC50 value of 23.8 µg/mL (MCF7 cancer cells) |
[129] |
Plant material | New Mexico, USA | Aqueous | n.s. | Effects on MCF-7/AZ breast cancer cells after 24 h of exposure | IC50 value of 50 µg/mL | [75,130] |
Spain | Essential oil | n.s. | Effects on NCI-H460 lung, MCF-7 breast, AGS gastric, and Caco-2 cancer cells after 24 h of exposure | IC50 values varying from 41.99 to 44.87 µg/mL (NCI-H460 cancer cells) IC50 values varying from 30.88 to 163.99 µg/mL (MCF-7 cancer cells) IC50 values varying from 132.68 to 302.86 µg/mL (AGS cancer cells) IC50 values varying from 107.65 to 230.79 µg/mL (Caco-2 cancer cells) |
||
Berries | Australia | Methanolic | n.s. | Effects on Caco-2 human colorectal and HeLa cervical cancer cells after 12 h of exposure | IC50 value of 1383 µg/mL (Caco-2 cancer cells) IC50 value of 2592 µg/mL (HeLa cancer cells) |
[131] |
Aqueous | n.s. | Effects on Caco-2 human colorectal and HeLa cervical cancer cells after 12 h of exposure | IC50 value of 1516 µg/mL (Caco-2 cancer cells) IC50 value of 2157 µg/mL (HeLa cancer cells) |
|||
Serbia | Essential oil and Distilled extracts | var. saxatilis | Effects on A549 human lung adenocarcinoma epithelial cells after 24 h of treatment after 24 h of exposure | Induced apoptosis and arrested cell cycle in G2/M IC50 value of 69.4 µg/mL (essential oil) IC50 value 1270 µg/mL (distilled extract) |
[71] | |
USA | Distilled extracts | n.s. | Effects on HepG2 human hepatocellular cancer cells after 24, 48, and 72 h of exposure | IC50 values of 48.9, 42.3, and 43.9 µg/mL, after 24, 48, and 72 h of exposure, respectively | [132,133] | |
Effects on Mahlavu human hepatocellular carcinoma cells after 24, 48, and 72 h of exposure | IC50 values of 64.9, 58.5, and 59.4 µg/mL, after 24, 48, and 72 h of exposure, respectively | |||||
Effects on J5 human hepatocellular carcinoma cells after 24, 48, and 72 h of exposure | IC50 values of 74.2, 67.2, and 53.2 µg/mL, after 24, 48, and 72 h of exposure, respectively | |||||
Effects on HT-29 colon cancer cells after 24, 48, and 72 h of exposure | Induced cell-cycle arrest at the G0/G1 phase via regulation of p53/p21 and CDK4/cyclin D1 Induced cell apoptosis via the extrinsic (FasL/Fas/caspase-8) and intrinsic (Bax/Bcl-2/caspase-9) apoptotic pathways IC50 values of 66.71, 60.02, and 54.32 µg/mL, after 24, 48, and 72 h of exposure, respectively |
|||||
Effects on CT-26 colon cancer cells after 24, 48, and 72 h of exposure | Induced cell-cycle arrest at the G0/G1 phase via regulation of p53/p21 and CDK4/cyclin D1 Induced cell apoptosis via the extrinsic (FasL/Fas/caspase-8) and intrinsic (Bax/Bcl-2/caspase-9) apoptotic pathways IC50 values of 27.8, 22.7, and 27.3 µg/mL, after 24, 48, and 72 h of exposure, respectively |
|||||
Leaves and branches | Wyoming, USA | Essential oil | n.s. | Effects on SH-SY5Y human neuroblastoma cells after 24 h of exposure | IC50 value of 53.7 µg/mL | [134] |
Seed cones | Serbia | Essential oil | var. saxatilis | Effects on HT-29 and HCT116 colon cancer cells after 24 h of exposure | IC50 value 125 µg/mL (HT-29) IC50 value of 62.5 µg/mL (HCT116) |
[93] |
Distilled extracts | IC50 value 625 µg/mL (HT-29) IC50 value of 1250 µg/mL (HCT116) |
|||||
Roots | China | Acetone | n.s. | Effects on N18 neuroblastoma cell lines after 24 and 48 h of exposure | Induced glioma cell-cycle arrest through intrinsic and extrinsic apoptotic pathways IC50 values of 61.11 and 68.94 µg/mL, after 24 and 48 h of exposure, respectively |
[135] |
Effects on DBTRG-05MG, G5T/VGH, GBM8401, GBM8901, and RG2 glioblastoma cell lines after 24 h of exposure | Induced glioma cell-cycle arrest through intrinsic and extrinsic apoptotic pathways IC50 value of 67.04 µg/mL (DBTRG-05MG glioblastoma cells) IC50 value of 63.3 µg/mL (G5T/VGH glioblastoma cells) IC50 value of 57.14 µg/mL (GBM8401glioblastoma cells) IC50 value of 58.45 µg/mL (GBM8901 glioblastoma cells) IC50 value of 69.97 µg/mL (RG2 glioblastoma cells) |
|||||
Effects on DBTRG-05MG, G5T/VGH, GBM8401, GBM8901, and RG2 glioblastoma cell lines after 48 h of exposure | Induced glioma cell-cycle arrest through intrinsic and extrinsic apoptotic pathways IC50 value of 49.46 µg/mL (DBTRG-05MG glioblastoma cells) IC50 value of 67.85 µg/mL (G5T/VGH glioblastoma cells) IC50 value of 46.68 µg/mL (GBM8401glioblastoma cells) IC50 value of 55.49 µg/mL (GBM8901 glioblastoma cells) IC50 value of 53.8 µg/mL (RG2 glioblastoma cells) |
|||||
In vivo assays | ||||||
Plant | USA | Distilled extracts | n.s. | Effects on melanoma tumor model in C57BL/6 mice after 23 days of treatment at a dose of 200 mg/kg | Cell-cycle arrest at the G0/G1 phase ↓↓ tumor size by 45.2%, B-cell lymphoma-2 (Bcl-2), procaspases 8 and 9 and higher levels of Bcl-2-associated X protein, apoptosis-inducing factor, cell-surface death receptor Fas and Fas ligand when compared to untreated control |
[73] |
Berries | USA | Distilled extracts | n.s. | Effects in BALB/c nude mice injected with HepG2 liver cancer cells at a dose of 200 mg/kg | ↓↓ tumor size ↑↑ lifespan with no or low systemic and pathological toxicity |
[132] |
Effects in female BALB/c mice injected with CT-16 colon cancer cells at a dose of 200 mg/kg | Inhibited proliferation Induced apoptosis No obvious change in body weight or histological morphology of normal organs after treatment |
[133] | ||||
Roots | China | Acetone | n.s. | Effects in male Foxn1 nu/nu mice injected with DBTRG-05MG human glioblastoma cells after 100 days of treatment at a dose of 200 mg/kg | Can penetrate the blood-brain barrier ↓↓ tumor size and the degree of neovascularization ↑↑ PCNA, VEGFR-1, and VEGFR-2 in 44.49%, 5.88%, and 5.85%, respectively, when compared to untreated control |
[135] |
Neuronal effects and anticataleptic activity | ||||||
In vitro assays | ||||||
Leaves | Turkey | Hydroethanolic (80% ethanol, v/v) |
var. alpina | Capacity to inhibit acetylcholinesterase activity | 10.38% inhibition at 50 µg/mL 24.30% inhibition at 100 µg/mL 32.89% inhibition at 200 µg/mL |
[61,107] |
Ripe Berries | Aqueous | 5.47% inhibition at 100 µg/mL 28.17% inhibition at 200 µg/mL |
||||
Shoots | Ethyl acetate, ethanolic, and acetone extracts | n.s. | 21.34% inhibition at 100 µg/mL (ethyl acetate extract) 13.46% inhibition at 100 µg/mL (ethanolic extract) 28.43% inhibition at 100 µg/mL (acetone extract) |
|||
Inhibitory percentages varying from 32.34 to 41.97%% inhibition at 100 µg/mL (ethyl acetate extract) Inhibitory percentages varying from 22.29 to 45.45% inhibition at 100 µg/mL (ethanolic extract) Inhibitory percentages varying from 1.91 to 38.55% inhibition at 100 µg/mL (acetone extract) | ||||||
Leaves | Ethyl acetate, ethanolic, and acetone extracts | n.s. | 20.02% inhibition at 100 µg/mL (ethyl acetate extract) 10.56% inhibition at 100 µg/mL (ethanolic extract) 32.34% inhibition at 100 µg/mL (acetone extract) |
|||
Ripe berries and leaves | Turkey | Aqueous | var. alpina | Capacity to inhibit butyrylcholinesterase activity | 25.87 (berries) and 25.33% (leaves) inhibition at 50 µg/mL 32.57 (berries) and 44.16% (leaves) inhibition at 100 µg/mL 36.97 (berries) and 62.01% (leaves) inhibition at 200 µg/mL |
[61,107] |
Hydroethanolic (80% ethanol, v/v) |
43.68 (berries) and 30.31% (leaves) inhibition at 50 µg/mL 45.19 (berries) and 33.17% (leaves) inhibition at 100 µg/mL 47.55 (berries) and 35.33% (leaves) inhibition at 200 µg/mL |
|||||
Unripe berries | Hydroethanolic (80% ethanol, v/v) |
44.17% inhibition at 50 µg/mL 48.96% inhibition at 100 µg/mL 49.95% inhibition at 200 µg/mL |
||||
In vivo assays | ||||||
Leaves | n.s. | Methanolic | n.s. | Effects on Wistar rats with induced Parkinson’s disease by chlorpromazine for 21 days at a dose of 200 mg/kg | ↑↑ locomotor activity ↓↓ motor dysfunctions, including catalepsy and muscle rigidity |
[19] |
Plant material | India | Methanolic | Effects on Wistar rats with induced catalepsy by reserpine 4 h after juniper treatment at a dose of 200 mg/kg | ↓↓ catalepsy activity | [34] | |
Romania | Essential oil | Effects of juniper volatile oil (1% and 3%) daily inhalation on Amyloid Beta (1–42) male Wistar rat model of Alzheimer’s disease after 21 days of treatment | ↑↑ working memory and reference memory errors within radial arm maze task ↓↓ spontaneous alternations percentage within Y-maze task |
[136] | ||
Effects of juniper volatile oil (1% and 3%) daily inhalation on Amyloid Beta (1–42)-induced oxidative stress in Wistar rats | ↑↑ acetylcholinesterase, superoxide dismutase and catalase activities, and malondialdehyde and protein carbonyl levels ↓↓ glutathione peroxidase-specific activity and the total content of the reduced glutathione |
[85] | ||||
Hepatoprotective effects | ||||||
In vivo assays | ||||||
Leaves | India | Ethyl acetate | n.s. | Effects on Wistar albino rats with hepatic damage caused by paracetamol for 14 days at a dose of 200 mg/kg | ↓↓ alkaline phosphatase (−57.41%), direct bilirubin (−30.33%) and total bilirubin (−38.41%), serum alanine aminotransferase (−34.17%), and serum aspartate aminotransferase (−27.58%) when compared to the untreated group Hepatoprotective effects with rearrangement promotion of portal triads and central veins |
[65] |
Stems | n.s. | Petroleum ether, chloroform, and ethanol extracts | n.s. | Effects on rats with hepatic damage caused by carbon tetrachloride | Hepatoprotective activity | [30] |
Co-combination of berries from juniper and Solanum xanthocarpum | India | Ethanolic | n.s. | Effects on Wistar albino rats with liver toxicity induced by paracetamol and azithromycin for 14 days at a dose of 200 mg/kg | ↓↓ serum glutamate oxaloacetate transaminase (−65.4%), serum glutamate pyruvate transaminase (−59.3%), alkaline phosphatase (66.8%), total bilirubin (62.1%), and liver inflammation Promoting liver tissue’s normal architecture |
[3] |
Tyrosinase inhibitory activity | ||||||
In vitro assays | ||||||
Berries | Republic of Korea | Methanolic | n.s. | Capacity to inhibit tyrosinase activity | about 50% inhibition at 100 µg/mL | [137] |
Renal effects | ||||||
In vivo assay | ||||||
Berries | Croatia | Aqueous | n.s. | Daily intake of 10% aqueous infusion, 0.1% of oil (with 0.2% Tween 20 solubilizer) by healthy female Wistar rats | ↑↑ diuresis and urine excretion without loss of electrolytes | [86] |
Antiurolithiasis effects | ||||||
In vitro assay | ||||||
Berries | Iran | Hydroethanolic (50% ethanol, v/v) |
n.s. | Capacity to dissolve urinary stone brought out from human kidney at concentrations of 500, 1000, and 2000 µg/mL | Dissolve urinary stones ↓↓ dry powder weight of stones ↑↑ the ratio of calcium oxalate in normal saline aqueous solution plus stone |
[138] |
Gastrointestinal effects | ||||||
In vivo assays | ||||||
Leaves | India | Methanolic (80% methanol, v/v) |
n.s. | Effects on adult male Wistar albino rats with ulcers induced by aspirin, serotonin, indomethacin, alcohol, and stress at doses of 50 and 100 mg/kg | ↓↓ aspirin, serotonin, indomethacin, alcohol, and stress-induced gastric ulcerations in rats ↑↑ healing rate of acetic acid-induced ulcers in rats |
[87] |
n.s. | Effects on pigs with histamine-induced duodenal lesions at doses of 50 and 100 mg/kg | ↓↓ histamine-induced duodenal lesions in pigs | ||||
Vessels and trachea protective effects in passive smoking | ||||||
In vitro assays | ||||||
Berries | Romania | Aerosols | n.s. | Effects of 3-week juniper aerosols (40 min/day) on female Sprague-Dawley rats firstly exposed to daily passive smoking for 6 weeks | ↓↓ acetylcholine endothelial-dependent relaxation | [139] |
Oil | n.s. | Effects of 3-week juniper nebulization (20 min/day) on the respiratory tract of rats which firstly exposed to 2 cigarettes per day, 5 days a week for 6 weeks | Bronchodilator effects mediated by nitric oxide | [140] | ||
Genotoxicity protective effects | ||||||
In vitro assays | ||||||
Berries | Romania | Hydroethanolic (50% ethanol, v/v) |
n.s. | Capacity to exhibit genoprotective effects against aberrations and abnormalities induced by ethanol on root-tip cells of Allium cepa L. | Can effectively protect chromosomes aberrations | [40] |
n.s.: not specified; IC50: half-maximal inhibitory concentration ↑↑: increase; ↓↓: reduction.